Activin receptor-like kinase 5 (ALK5) inhibitors: a patent review (2013-present).

Huang XY, Yu CQ, Wang X, Guo Z, Jin CH

DOI: 10.1080/13543776.2026.2660906
Published: 2026 May
Container: Expert opinion on therapeutic patents
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/13543776.2026.2660906,
  title = {Activin receptor-like kinase 5 (ALK5) inhibitors: a patent review (2013-present).},
  author = {Huang XY and Yu CQ and Wang X and Guo Z and Jin CH},
  year = {2026},
  journal = {Expert opinion on therapeutic patents},
  doi = {10.1080/13543776.2026.2660906},
  url = {https://doi.org/10.1080/13543776.2026.2660906}
}

RIS

TY  - JOUR
TI  - Activin receptor-like kinase 5 (ALK5) inhibitors: a patent review (2013-present).
AU  - Huang XY
AU  - Yu CQ
AU  - Wang X
AU  - Guo Z
AU  - Jin CH
PY  - 2026
JO  - Expert opinion on therapeutic patents
DO  - 10.1080/13543776.2026.2660906
UR  - https://doi.org/10.1080/13543776.2026.2660906
ER  -

APA

XY, H., CQ, Y., X, W., Z, G., & CH, J. (2026). Activin receptor-like kinase 5 (ALK5) inhibitors: a patent review (2013-present).. Expert opinion on therapeutic patents. https://doi.org/10.1080/13543776.2026.2660906

Source records

pubmed · retrieved 2026-09-26T22:37:26.262Z